Stimulation of endogenous pulsatile growth hormone secretion by activation of growth hormone secretagogue receptor reduces the fat accumulation and improves the insulin sensitivity in obese mice.

RPEP-05455Preclinical Animal StudyModerate2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Preclinical Animal Study
Evidence
Moderate
Sample
N=Animal study (MC4RKO obese mice)
Participants
MC4R knockout obese mice (pair-fed)

What This Study Found

Hexarelin (10.56 mcg/day continuous infusion) increased pulsatile GH secretion in MC4RKO obese mice, reducing visceral fat and liver triglycerides while improving insulin sensitivity without altering IGF-1 or insulin levels.

Key Numbers

10.56 mcg/day hexarelin; 3-4 weeks; increased pulsatile GH; reduced visceral fat; reduced liver TG; improved insulin sensitivity; no IGF-1/insulin change

How They Did This

MC4R knockout obese mice pair-fed and infused continuously with hexarelin (10.56 mcg/day) or vehicle via osmotic pump for 3-4 weeks. Pulsatile GH secretion, lipolysis, lipid oxidation, de novo lipogenesis, insulin sensitivity, glucose tolerance, and GH signaling gene expression measured.

Why This Research Matters

Obesity reduces GH secretion, creating a vicious cycle of more fat storage. Restoring pulsatile GH release with a small peptide could break this cycle without the side effects of direct GH injection (which raises IGF-1 and can worsen insulin resistance).

What This Study Doesn't Tell Us

Mouse model (MC4RKO, not typical human obesity). Pair-fed design controls for food intake but limits ecological validity. Continuous hexarelin infusion via pump is not practical for human use. Only 3-4 weeks of treatment. Hexarelin is not FDA-approved.

Trust & Context

Original Title:
Stimulation of endogenous pulsatile growth hormone secretion by activation of growth hormone secretagogue receptor reduces the fat accumulation and improves the insulin sensitivity in obese mice.
Published In:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 35(1), e21269 (2021)
Database ID:
RPEP-05455

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Cite This Study

RPEP-05455·https://rethinkpeptides.com/research/RPEP-05455

APA

Huang, Zhengxiang; Lu, Xuehan; Huang, Lili; Zhang, Chunhong; Veldhuis, Johannes D; Cowley, Michael A; Chen, Chen. (2021). Stimulation of endogenous pulsatile growth hormone secretion by activation of growth hormone secretagogue receptor reduces the fat accumulation and improves the insulin sensitivity in obese mice.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 35(1), e21269. https://doi.org/10.1096/fj.202001924RR

MLA

Huang, Zhengxiang, et al. "Stimulation of endogenous pulsatile growth hormone secretion by activation of growth hormone secretagogue receptor reduces the fat accumulation and improves the insulin sensitivity in obese mice.." FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021. https://doi.org/10.1096/fj.202001924RR

RethinkPeptides

RethinkPeptides Research Database. "Stimulation of endogenous pulsatile growth hormone secretion..." RPEP-05455. Retrieved from https://rethinkpeptides.com/research/huang-2021-stimulation-of-endogenous-pulsatile

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.